WebSep 18, 2024 · National Center for Biotechnology Information WebMethods: Seventeen patients with esophageal cancer were enrolled between July 2014 and December 2015.The treatment included radical radiotherapy (95% planning target volume 60Gy/30f) and concurrent chemotherapy comprising nab-paclitaxel 60mg/m2/week plus cisplatin 25mg/m2/week, administered on days 1, 8, 15, and 22 of each 28-day cycle.
Cites background from "Bladder preservation by neoadjuvant..."
WebSep 25, 2015 · Chemotherapy was cisplatin 35 mg/m 2 once weekly unless contraindicated when weekly AUC2 carboplatin was used. For patients planned with an empty bladder a hand-held ultrasound was performed daily prior to treatment to ensure the bladder was empty. WebNone of the RTOG trials had this approach, but extrapolating from head and neck cancer (cisplatin 30mg/m2) or cervical cancer (40mg/m2), people in the community are using weekly cisplatin. As far as data, there is a phase II study from Australia utilizing cisplatin 35mg/m2 weekly for 6-7 cycles show... early signs of jaundice in adults
Cisplatin (Cisplatin Injection): Uses, Dosage, Side Effects ... - RxList
WebFeb 11, 2024 · Cisplatin was given either at a dose of 100 mg/m 2 every 3 weeks (day 1, 22, and 43) during RT (University Hospital Basel) to a planned cumulative dose of 300 … WebA phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study . × Close Log In. Log in with Facebook Log in with Google. or. Email. Password. Remember me on this computer. or reset password. Enter the email address you signed up with and we'll ... WebTreatment consisted of 5-Fluorouracil (5-FU) on cis-platinum (CDDP). 5-FU was given at 1000 mg/m2 per day as continuous infusions during 4 days, and 60 mg/m2 of CDDP was given on day 4 beginning on day 1 and 35 of a concurrent chemoradiotherapy course. ... Radiation was given in single daily fractions of 2 Gy and 5 fractions per week to a total ... early signs of increased cranial pressure